Surgical intervention in infective endocarditis: Indications and timing

Harefuah

Volumn 144, Issue 6, 2005, Pages 421-425

  Rav Acha, Moshe ^a   Sassa, David ^a   Ilan, Yaron ^a   Milgalter, Eli ^a   Lotan, Chaim ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Endocarditis; Stroke; Surgical; Timing; Treatment

Indexed keywords

BACTERIAL ENDOCARDITIS; CARDIOVASCULAR SURGERY; REVIEW; TREATMENT INDICATION; EMBOLISM; ENDOCARDITIS; HEART SURGERY; HUMAN; INFECTION; METHODOLOGY;

CARDIAC SURGICAL PROCEDURES; EMBOLISM; ENDOCARDITIS; HUMANS; INFECTION;

EID: 22444439890     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Major RH, Notes on the history of endocarditis. Bull Hist Med, 1945; 17: 351-356.
2. Osier W, The Gustonian lectures on malignant endocarditis. Br Med J, 1885; 1: 11-20.
3. Olaison L & Pettersson G, Current best practices and guidelines: indications for surgical intervention in infective endocarditis. Inf Dis Clin North Am, 2002; 16: 453-475.
4. Olaison L & Pettersson G, Current best practices and guidelines: indications for surgical intervention in infective endocarditis. Cardiol Clin, 2003; 21: 235- 251.
5. Wallace AG, Young WG & Osterhout S, Treatment of acute bacterial endocarditis by valve excision and replacement. Circulation, 1965; 31: 450-453.
6. th ed. pp 809-816. USA, McGraw-Hill Companies, 2001.
7. Bayer AS, Bolger AF, Kathryn A & al, Diagnosis and management of infective endocarditis and its complications. Circulation, 1998; 98: 2936-2948.
8. Moon MR, Stinson EB & Miller DC, Surgical treatment of endocarditis. Prog Cardiovasc Dis, 1997; 40: 239-264.
9. Vlessis AA, Hovaguimian H, Jaggers J & al, Infective endocardits: ten-year review of medical and surgical therapy. Ann Thorac Surg, 1996; 61: 1217-1222.
10. Mills J, Utley J & Abbott J, Heart failure in infective endocarditis: predisposing factors, course and treatment. Chest, 1974; 66: 151-158.
11. Alexiou C, Stephen FR, Langley M & al, Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg, 2000; 69: 1448-1454.
12. Jault D, Gandjbakhch I, Rama A & al, Active native valve endocarditis: determinants of perioperative death and late mortality. Ann Thorac Surg, 1997; 63: 1737-1741.
13. D'Udekem Y, David TE, Feindel CM & al, Long-term results of surgery for active infective endocarditis. Eur J Cardiothoracic Surg, 1997; 11:46-52.
14. Croft CH, Woodward W, Elliot A & al, Analysis of surgical versus medical therapy in active complicated native valve endocarditis. Am J Cardiol, 1983; 51: 1650-1655.
15. Griffin FM, Jones G & Cobbs CG, Aortic insufficiency in bacterial endocarditis. Ann Int Med, 1972; 76: 23-28.
16. Blumberg EA, Karalis DA, Chandrasekaran K & al, Endocarditis- associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest, 1995; 107: 898-903.
17. Choussat R, Thomas D, Isnard R & al, Perivalvular abscesses associated with endocarditis: clinical features and prognostic factors of overall survival in a series of cases. Eur Heart J, 1999; 20: 170-171.
18. Daniel W, Mugge A, Martin R & al, Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardigraphy. N Eng J Med, 1991; 324: 795-800.
19. Lerakis S, Robert Taylor W, Lynch M & al, The role of transesophageal echocardiography in the diagnostic management of patients with aortic paravalvular abscesses. Am J Med Sci, 2001; 321: 152-155.
20. Heiro M, Nikoskelainen J, Engblom E & al, Neurologic menifestations of infective endocarditis: a 17-year experience in a teaching hospital in finland. Arch Int Med, 2000; 160: 2781-2787.
21. Steckelberg JM, Murphy JG, Ballard D & al, Emboli in infective endocarditis: the prognostic value of echocardigraphy. Ann Int Med, 1991; 114: 635-640.
22. Di Salvo G, Habib G, Pergola v & al, Echocardigraphy predicts embolic events in infective endocarditis. J Am Coll Cardiol, 2001; 37: 1069-1076.
23. Rohmann S, Erbel R, Gorge G & al, Clinical relevance of vegetation localization by trans-esophageal echocardiography in infective endocarditis. Eur Heart J, 1992; 13: 446-452.
24. De Castro S, Magni G, Beni S & al, Role of transthoracic and transesophageal echocardiography in predicting embolic events with active infective endocarditis involving native cardiac valves. Am J Cardiol, 1997; 80: 1030-1034.
25. Heinle S, Wilderman N, Harrison K & al, Value of transthoracic echocardigraphy in predicting embilc events in active infective endocarditis. Am J Cardiol, 1994; 74: 799-801.
26. Olaison L, Belin L, Hogevik H & al, Incidence of betalactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis. Arch Int Med, 1999; 159: 607-615.
27. Nguyen MH, Nguyen ML, Yu Vl & al, Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis, 1996; 22: 262-267.
28. Calderwood SB, Swinski LA, Karchmer AW & al, Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg, 1986; 92: 776-783.
29. Yu VL, Fang GD, Keys TF & al, Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg, 1994; 58: 1073-1077.
30. Kiyoyuki E, Kawazoe K, Yoshihiro K & al, Surgical management of infective endocarditis associated with cerebral complications. J Thorac Cardiovasc Surg, 1995; 110: 1745-1755.
31. Ting W, Silverman N & Levitsky S, Valve replacement in patients with endocarditis and cerebral septic emboli. Ann Thorac Surg, 1991; 51: 18-22.